RIPK3 and inflammatory bowel disease: RIPK3 promotes nuclear RelB-p50 activation and caspase-1-mediated pro-IL-1 processing in DCs, ensuring optimum IL-23 and IL-1 expression [84], implying that RIPK3 may facilitate the pathogenesis of IBD.